Detalles de la búsqueda
1.
Determinants of Acquisition and Clearance of Human Papillomavirus Infection in Previously Unexposed Young Women.
Sex Transm Dis;
46(10): 663-669, 2019 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-31464859
2.
Methylation in host and viral genes as marker of aggressiveness in cervical lesions: Analysis in 543 unscreened women.
Gynecol Oncol;
151(2): 319-326, 2018 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-30172480
3.
Prior human papillomavirus-16/18 AS04-adjuvanted vaccination prevents recurrent high grade cervical intraepithelial neoplasia after definitive surgical therapy: Post-hoc analysis from a randomized controlled trial.
Int J Cancer;
139(12): 2812-2826, 2016 Dec 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-27541373
4.
Risk of newly detected infections and cervical abnormalities in women seropositive for naturally acquired human papillomavirus type 16/18 antibodies: analysis of the control arm of PATRICIA.
J Infect Dis;
210(4): 517-34, 2014 Aug 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-24610876
5.
Risk of first cervical HPV infection and pre-cancerous lesions after onset of sexual activity: analysis of women in the control arm of the randomized, controlled PATRICIA trial.
BMC Infect Dis;
14: 551, 2014 Oct 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-25927224
6.
Efficacy of the HPV-16/18 AS04-adjuvanted vaccine against low-risk HPV types (PATRICIA randomized trial): an unexpected observation.
J Infect Dis;
208(9): 1391-6, 2013 Nov 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-24092907
7.
Overall efficacy of HPV-16/18 AS04-adjuvanted vaccine against grade 3 or greater cervical intraepithelial neoplasia: 4-year end-of-study analysis of the randomised, double-blind PATRICIA trial.
Lancet Oncol;
13(1): 89-99, 2012 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-22075171
8.
Prevalence and risk factors for cervical HPV infection and abnormalities in young adult women at enrolment in the multinational PATRICIA trial.
Gynecol Oncol;
127(3): 440-50, 2012 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-22940493
9.
Prevalence of human papillomavirus infection and associated risk factors in young women in Brazil, Canada, and the United States: a multicenter cross-sectional study.
Int J Gynecol Pathol;
30(2): 173-84, 2011 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-21293281
10.
Efficacy of a prophylactic adjuvanted bivalent L1 virus-like-particle vaccine against infection with human papillomavirus types 16 and 18 in young women: an interim analysis of a phase III double-blind, randomised controlled trial.
Lancet;
369(9580): 2161-2170, 2007 Jun 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-17602732
11.
Evaluation of Type Replacement Following HPV16/18 Vaccination: Pooled Analysis of Two Randomized Trials.
J Natl Cancer Inst;
109(7)2017 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-28132019
12.
Incidence and duration of type-specific human papillomavirus infection in high-risk HPV-naïve women: results from the control arm of a phase II HPV-16/18 vaccine trial.
BMJ Open;
6(8): e011371, 2016 08 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-27566633
13.
Efficacy of a bivalent L1 virus-like particle vaccine in prevention of infection with human papillomavirus types 16 and 18 in young women: a randomised controlled trial.
Lancet;
364(9447): 1757-65, 2004.
Artículo
en Inglés
| MEDLINE | ID: mdl-15541448
14.
Sustained efficacy, immunogenicity, and safety of the HPV-16/18 AS04-adjuvanted vaccine: final analysis of a long-term follow-up study up to 9.4 years post-vaccination.
Hum Vaccin Immunother;
10(8): 2147-62, 2014.
Artículo
en Inglés
| MEDLINE | ID: mdl-25424918
15.
Malignant syphilis in an HIV seropositive woman.
Int J Gynaecol Obstet;
102(3): 297-8, 2008 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-18457838
16.
Natural history of progression of HPV infection to cervical lesion or clearance: analysis of the control arm of the large, randomised PATRICIA study.
PLoS One;
8(11): e79260, 2013.
Artículo
en Inglés
| MEDLINE | ID: mdl-24260180
17.
Sustained immunogenicity and efficacy of the HPV-16/18 AS04-adjuvanted vaccine: up to 8.4 years of follow-up.
Hum Vaccin Immunother;
8(3): 390-7, 2012 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-22327492
18.
Maternal group B streptococcal immunization: capsular polysaccharide (CPS)-based vaccines and their implications on prevention.
Vaccine;
29(21): 3729-30, 2011 May 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-21414381
19.
Acquisition and transmission of group B Streptococcus during pregnancy.
J Infect Dis;
198(9): 1375-8, 2008 Nov 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-18774883
Resultados
1 -
19
de 19
1
Próxima >
>>